OXAZEPAM

OXAZEPAM was reported 22148 times

OXAZEPAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DYSTONIC TREMOR 34 0.3864
1 SEDATION COMPLICATION 541 0.2118
2 WRONG PATIENT 89 0.1773
3 ILLICIT PRESCRIPTION ATTAINMENT 18 0.1500
4 CREATININE RENAL CLEARANCE DECREASED 540 0.1348
5 HYPER IGE SYNDROME 15 0.1316
6 ASTEATOSIS 15 0.1271
7 MULTIPLE DRUG THERAPY 91 0.1207
8 CHEMICAL SUBMISSION 28 0.1107
9 VISCERAL CONGESTION 42 0.0822
10 CREATININE RENAL CLEARANCE INCREASED 61 0.0816
11 SUBSTANCE USE DISORDER 246 0.0771
12 VICTIM OF SEXUAL ABUSE 36 0.0684
13 SENSORY OVERLOAD 13 0.0660
14 POISONING DELIBERATE 621 0.0654
15 HYPERDYNAMIC LEFT VENTRICLE 16 0.0650
16 FAECAL VOMITING 34 0.0639
17 ACETONAEMIA 15 0.0595
18 PATIENT UNCOOPERATIVE 27 0.0570
19 REDUCED FACIAL EXPRESSION 56 0.0552
20 BEZOAR 72 0.0522
21 DRUG USE DISORDER 409 0.0486
22 BLOOD CALCIUM DECREASED 547 0.0486
23 VICTIM OF CHEMICAL SUBMISSION 31 0.0462
24 BRADYPNOEA 122 0.0452
25 PANCREAS INFECTION 18 0.0448
26 NEONATAL RESPIRATORY DISTRESS 42 0.0445
27 WRONG PATIENT RECEIVED PRODUCT 130 0.0444
28 ORTHOSTATIC HYPOTENSION 763 0.0438
29 VICTIM OF CRIME 54 0.0437
30 POSTMORTEM BLOOD DRUG LEVEL INCREASED 16 0.0429
31 MIOSIS 341 0.0424
32 PHARMACEUTICAL NOMADISM 21 0.0410
33 ASPHYXIA 329 0.0403
34 MONOCYTOSIS 24 0.0386
35 BLADDER DILATATION 38 0.0349
36 HOUSEBOUND 13 0.0327
37 OPIATES POSITIVE 15 0.0312
38 ACCIDENTAL POISONING 41 0.0299
39 SEDATION 779 0.0297
40 SUBSTANCE ABUSE 239 0.0293
41 POISONING 366 0.0291
42 ANTEROGRADE AMNESIA 17 0.0284
43 PRESCRIPTION FORM TAMPERING 21 0.0272
44 PLEUROTHOTONUS 24 0.0265
45 VASOPLEGIA SYNDROME 43 0.0262
46 LOGORRHOEA 90 0.0255
47 COMA 1163 0.0244
48 SMALL FIBRE NEUROPATHY 18 0.0244
49 DEPRESSED LEVEL OF CONSCIOUSNESS 964 0.0243
50 OESOPHAGEAL OBSTRUCTION 20 0.0230
51 FIBROMA 21 0.0229
52 ACCIDENTAL DEATH 42 0.0226
53 HEPATOBILIARY DISEASE 14 0.0224
54 TROPONIN T INCREASED 28 0.0221
55 EOSINOPHILIC MYOCARDITIS 16 0.0219
56 PSYCHOTIC BEHAVIOUR 22 0.0217
57 STOMA SITE REACTION 14 0.0204
58 POTENTIATING DRUG INTERACTION 68 0.0202
59 OESOPHAGEAL ACHALASIA 13 0.0202
60 HEPATIC CYTOLYSIS 257 0.0201
61 RESPIRATORY DEPRESSION 242 0.0197
62 DRUG ABUSE 1553 0.0186
63 HAEMATOMA MUSCLE 22 0.0183
64 TOXICITY TO VARIOUS AGENTS 3051 0.0181
65 DISSOCIATIVE DISORDER 13 0.0180
66 COGNITIVE DISORDER 837 0.0179
67 HYPOTHERMIA 177 0.0175
68 HYPERTHERMIA 128 0.0167
69 MIXED LIVER INJURY 50 0.0166
70 BRADYKINESIA 98 0.0166
71 LABELLED DRUG-DRUG INTERACTION ISSUE 24 0.0166
72 FOETAL GROWTH RESTRICTION 100 0.0164
73 HYPOCOAGULABLE STATE 16 0.0164
74 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 23 0.0164
75 RENAL FUNCTION TEST ABNORMAL 75 0.0161
76 CHOLESTATIC LIVER INJURY 35 0.0157
77 PYELOCALIECTASIS 15 0.0157
78 LISTLESS 51 0.0155
79 MUTISM 22 0.0151
80 HYPERKINESIA 32 0.0151
81 HYPERCAPNIA 45 0.0149
82 HEPATIC CONGESTION 14 0.0148
83 KETOSIS 16 0.0147
84 ALTERED STATE OF CONSCIOUSNESS 315 0.0145
85 MULTIPLE DRUG OVERDOSE 72 0.0145
86 RESPIRATORY ACIDOSIS 55 0.0140
87 PRODUCT MONITORING ERROR 20 0.0138
88 STOMA SITE PAIN 20 0.0136
89 HOMICIDE 25 0.0136
90 DRUG WITHDRAWAL CONVULSIONS 24 0.0135
91 BEHAVIOUR DISORDER 73 0.0135
92 STOMA SITE ERYTHEMA 25 0.0134
93 ACQUIRED HAEMOPHILIA 13 0.0130
94 ON AND OFF PHENOMENON 72 0.0130
95 DILATED CARDIOMYOPATHY 13 0.0129
96 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 132 0.0128
97 PERSECUTORY DELUSION 31 0.0124
98 DISINHIBITION 20 0.0124
99 MYDRIASIS 159 0.0124
100 RESPIRATORY ALKALOSIS 20 0.0123
101 VESTIBULAR DISORDER 15 0.0122
102 HYPOTONIA NEONATAL 19 0.0122
103 MEGACOLON 19 0.0121
104 PNEUMONIA ASPIRATION 301 0.0120
105 STENOSIS 22 0.0117
106 CARDIAC HYPERTROPHY 13 0.0117
107 ARTERIOSCLEROSIS CORONARY ARTERY 76 0.0115
108 PSYCHOMOTOR RETARDATION 32 0.0114
109 SEROTONIN SYNDROME 218 0.0113
110 BRADYPHRENIA 74 0.0113
111 FREEZING PHENOMENON 41 0.0111
112 BLOOD PRESSURE DIASTOLIC ABNORMAL 28 0.0110
113 CLONUS 30 0.0110
114 INTENTIONAL OVERDOSE 698 0.0109
115 NEUROLEPTIC MALIGNANT SYNDROME 129 0.0109
116 HEPATITIS ACUTE 70 0.0108
117 PROTHROMBIN TIME SHORTENED 15 0.0107
118 ANTIPSYCHOTIC DRUG LEVEL INCREASED 30 0.0106
119 SUBILEUS 22 0.0106
120 HYPOVENTILATION 33 0.0101
121 DRUG LEVEL ABOVE THERAPEUTIC 46 0.0100
122 ELECTROCARDIOGRAM QT PROLONGED 361 0.0100
123 MULTIPLE CONGENITAL ABNORMALITIES 14 0.0097
124 HAEMODYNAMIC INSTABILITY 74 0.0097
125 TOXIC EPIDERMAL NECROLYSIS 147 0.0097
126 COMA SCALE ABNORMAL 28 0.0097
127 MUSCLE RIGIDITY 113 0.0094
128 BRAIN OEDEMA 118 0.0093
129 VASCULAR PURPURA 13 0.0093
130 PSYCHIATRIC DECOMPENSATION 18 0.0092
131 AKINESIA 19 0.0092
132 AUDITORY DISORDER 13 0.0092
133 STOMA SITE DISCHARGE 25 0.0091
134 SUICIDE ATTEMPT 552 0.0091
135 HEPATIC FIBROSIS 31 0.0090
136 LARGE INTESTINAL OBSTRUCTION 20 0.0089
137 MOBILITY DECREASED 643 0.0089
138 BALANCE DISORDER 772 0.0089
139 AGGRESSION 446 0.0089
140 ACUTE PULMONARY OEDEMA 50 0.0089
141 MUSCLE CONTRACTURE 18 0.0089
142 GALLBLADDER INJURY 17 0.0087
143 LIVEDO RETICULARIS 18 0.0086
144 ESCHERICHIA BACTERAEMIA 20 0.0085
145 BLOOD PRESSURE SYSTOLIC ABNORMAL 21 0.0085
146 TROPONIN I INCREASED 14 0.0084
147 PSYCHOMOTOR SKILLS IMPAIRED 22 0.0084
148 DISTRIBUTIVE SHOCK 19 0.0084
149 RHEUMATOID NODULE 23 0.0083
150 FOOD AVERSION 14 0.0082
151 TONGUE BITING 17 0.0082
152 ASPIRATION 90 0.0082
153 HYPERLACTACIDAEMIA 22 0.0082
154 MULTIPLE DRUG OVERDOSE INTENTIONAL 26 0.0081
155 HYPOGLYCAEMIA NEONATAL 13 0.0080
156 CEREBRAL HAEMATOMA 27 0.0080
157 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 21 0.0080
158 HYPONATRAEMIA 446 0.0079
159 RESTLESSNESS 288 0.0079
160 VOCAL CORD PARALYSIS 14 0.0078
161 DRUG INTERACTION 1238 0.0078
162 DRUG LEVEL INCREASED 128 0.0077
163 CARDIOPULMONARY FAILURE 30 0.0077
164 HYPERAMMONAEMIC ENCEPHALOPATHY 13 0.0075
165 LICHENOID KERATOSIS 17 0.0074
166 LYMPHOCYTOSIS 16 0.0074
167 WRONG PRODUCT ADMINISTERED 50 0.0074
168 POSTURE ABNORMAL 24 0.0074
169 BLOOD PRESSURE DIASTOLIC INCREASED 34 0.0074
170 PRE-ECLAMPSIA 35 0.0074
171 FEBRILE BONE MARROW APLASIA 31 0.0073
172 SCHIZOAFFECTIVE DISORDER 13 0.0073
173 DRUG TOXICITY 99 0.0073
174 INTENTIONAL SELF-INJURY 146 0.0072
175 HYPOTENSION 1448 0.0072
176 CHOLECYSTITIS INFECTIVE 20 0.0072
177 MYOCLONUS 85 0.0071
178 PNEUMONIA STAPHYLOCOCCAL 14 0.0071
179 PARKINSONISM 69 0.0071
180 TORSADE DE POINTES 55 0.0070
181 STATUS EPILEPTICUS 79 0.0070
182 ENCEPHALOPATHY 171 0.0070
183 TACHYPHRENIA 24 0.0069
184 LIBIDO INCREASED 14 0.0069
185 CHOLESTASIS 132 0.0069
186 DRUG SCREEN FALSE POSITIVE 19 0.0069
187 BIPOLAR I DISORDER 15 0.0068
188 DRUG DIVERSION 42 0.0068
189 PSYCHOTIC SYMPTOM 14 0.0068
190 DYSARTHRIA 255 0.0068
191 ALCOHOL POISONING 18 0.0067
192 INCREASED BRONCHIAL SECRETION 17 0.0066
193 NYSTAGMUS 35 0.0066
194 TENSION 40 0.0066
195 CARDIO-RESPIRATORY ARREST 274 0.0065
196 HALLUCINATION, VISUAL 138 0.0065
197 BLOOD TESTOSTERONE INCREASED 14 0.0065
198 HYPOMAGNESAEMIA 90 0.0065
199 HYPERTONIA 37 0.0065
200 ELECTRIC SHOCK SENSATION 18 0.0064
201 BRADYCARDIA 333 0.0063
202 AGRANULOCYTOSIS 116 0.0062
203 RESPIRATORY DISTRESS 172 0.0062
204 BLOOD PRESSURE DIASTOLIC DECREASED 46 0.0062
205 CORONARY ARTERY STENOSIS 31 0.0062
206 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 38 0.0061
207 PERSONALITY DISORDER 16 0.0061
208 CYTOLYTIC HEPATITIS 20 0.0060
209 SINUS BRADYCARDIA 58 0.0060
210 HYPERAMMONAEMIA 30 0.0060
211 FOREIGN BODY 24 0.0060
212 CARDIOGENIC SHOCK 86 0.0060
213 ALCOHOL ABUSE 16 0.0060
214 APATHY 87 0.0060
215 DELIRIUM 207 0.0060
216 SHOCK 137 0.0060
217 DISORIENTATION 235 0.0059
218 FINE MOTOR SKILL DYSFUNCTION 17 0.0059
219 FAECALOMA 32 0.0058
220 PULMONARY OEDEMA 259 0.0058
221 SINUS TACHYCARDIA 82 0.0058
222 PULMONARY CONGESTION 76 0.0058
223 RHABDOMYOLYSIS 240 0.0057
224 IMMOBILE 25 0.0057
225 METABOLIC ENCEPHALOPATHY 17 0.0057
226 ACUTE RESPIRATORY DISTRESS SYNDROME 99 0.0056
227 TOXIC ENCEPHALOPATHY 28 0.0055
228 HYPOTONIA 55 0.0055
229 BRAIN DEATH 17 0.0055
230 AUTONOMIC NERVOUS SYSTEM IMBALANCE 16 0.0055
231 HYPOKALAEMIA 252 0.0055
232 LUMBAR VERTEBRAL FRACTURE 25 0.0055
233 DRUG SCREEN POSITIVE 43 0.0054
234 HYPOMANIA 20 0.0054
235 AGITATION 397 0.0054
236 RASH MACULO-PAPULAR 120 0.0054
237 PELVIC FRACTURE 42 0.0054
238 COMPLETED SUICIDE 446 0.0053
239 MAJOR DEPRESSION 39 0.0053
240 STUPOR 17 0.0053
241 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 136 0.0053
242 SUDDEN CARDIAC DEATH 18 0.0053
243 LACTIC ACIDOSIS 169 0.0052
244 ABNORMAL BEHAVIOUR 205 0.0052
245 SOMNOLENCE 1033 0.0051
246 OXYGEN SATURATION DECREASED 286 0.0051
247 OVERWEIGHT 27 0.0050
248 HYPOVOLAEMIC SHOCK 24 0.0050
249 COMPARTMENT SYNDROME 13 0.0050
250 CONFUSIONAL STATE 795 0.0049
251 SUDDEN DEATH 52 0.0049
252 DYSCHEZIA 15 0.0049
253 METABOLIC ACIDOSIS 157 0.0049
254 DERMATITIS EXFOLIATIVE GENERALISED 17 0.0049
255 APNOEA 38 0.0049
256 EXTRAPYRAMIDAL DISORDER 121 0.0049
257 HYPOGLYCAEMIC COMA 14 0.0049
258 URINARY RETENTION 161 0.0048
259 HEART DISEASE CONGENITAL 17 0.0048
260 GASTROINTESTINAL NECROSIS 14 0.0048
261 ERYSIPELAS 24 0.0048
262 CLUMSINESS 13 0.0048
263 DELUSION 74 0.0048
264 HALLUCINATIONS, MIXED 20 0.0048
265 REGURGITATION 16 0.0047
266 CUTANEOUS VASCULITIS 17 0.0047
267 CONCUSSION 36 0.0046
268 FALL 1545 0.0046
269 EOSINOPHILIA 81 0.0046
270 MICTURITION DISORDER 16 0.0046
271 ALCOHOL USE 17 0.0046
272 SPINAL STENOSIS 19 0.0046
273 AKATHISIA 62 0.0045
274 ACCIDENTAL OVERDOSE 166 0.0045
275 GENERALISED TONIC-CLONIC SEIZURE 75 0.0045
276 CARDIAC FAILURE ACUTE 30 0.0045
277 DISTURBANCE IN ATTENTION 241 0.0045
278 ACUTE KIDNEY INJURY 678 0.0044
279 SHOCK HAEMORRHAGIC 36 0.0044
280 HEPATIC FAILURE 132 0.0044
281 PSYCHOTIC DISORDER 129 0.0044
282 AFFECT LABILITY 42 0.0044
283 MYOCARDITIS 50 0.0044
284 BLOOD PRESSURE SYSTOLIC INCREASED 85 0.0044
285 BRAIN HERNIATION 13 0.0043
286 PSYCHIATRIC SYMPTOM 32 0.0043
287 BLADDER DISORDER 43 0.0043
288 ACIDOSIS 33 0.0043
289 HYPERVENTILATION 25 0.0043
290 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 22 0.0043
291 ATRIOVENTRICULAR BLOCK 33 0.0043
292 BODY TEMPERATURE DECREASED 42 0.0043
293 HYPERNATRAEMIA 21 0.0042
294 PANCREATITIS ACUTE 94 0.0042
295 THYROID MASS 16 0.0042
296 TACHYCARDIA 370 0.0042
297 HEPATOCELLULAR INJURY 59 0.0042
298 LOW BIRTH WEIGHT BABY 33 0.0041
299 ATRIOVENTRICULAR BLOCK FIRST DEGREE 18 0.0041
300 MANIA 68 0.0041
301 STRESS CARDIOMYOPATHY 24 0.0041
302 PRIAPISM 14 0.0041
303 CONCOMITANT DISEASE AGGRAVATED 25 0.0040
304 HYPERKALAEMIA 142 0.0040
305 BLOOD ALBUMIN DECREASED 32 0.0040
306 INCOHERENT 26 0.0040
307 PARTIAL SEIZURES 21 0.0040
308 CONSTIPATION 872 0.0040
309 BLOOD LACTIC ACID INCREASED 21 0.0040
310 OVERDOSE 851 0.0039
311 ECCHYMOSIS 27 0.0039
312 DYSKINESIA 160 0.0039
313 SUICIDAL IDEATION 359 0.0039
314 HAEMOLYTIC ANAEMIA 35 0.0039
315 POOR QUALITY SLEEP 84 0.0039
316 HYPERTENSIVE CRISIS 43 0.0039
317 SOCIAL PROBLEM 16 0.0039
318 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 30 0.0039
319 COLITIS ISCHAEMIC 26 0.0039
320 MULTIPLE ORGAN DYSFUNCTION SYNDROME 109 0.0038
321 HEAD DISCOMFORT 68 0.0038
322 LEUKOCYTOSIS 69 0.0038
323 ILEUS PARALYTIC 17 0.0038
324 HYPOXIA 134 0.0038
325 SALIVARY HYPERSECRETION 38 0.0038
326 INTENTIONAL PRODUCT MISUSE 331 0.0038
327 HYPOCALCAEMIA 71 0.0037
328 DRUG ABUSER 23 0.0037
329 ALCOHOLISM 16 0.0037
330 PSYCHOMOTOR HYPERACTIVITY 62 0.0037
331 HYPERREFLEXIA 13 0.0037
332 CARDIOTOXICITY 33 0.0037
333 RENAL TUBULAR NECROSIS 36 0.0037
334 COORDINATION ABNORMAL 51 0.0037
335 SELF-MEDICATION 15 0.0036
336 EPILEPSY 111 0.0036
337 HYPOGLYCAEMIA 176 0.0036
338 SCHIZOPHRENIA 44 0.0036
339 PURPURA 32 0.0036
340 FAECES HARD 14 0.0036
341 NECROSIS 20 0.0036
342 THROMBOTIC MICROANGIOPATHY 35 0.0036
343 WITHDRAWAL SYNDROME 150 0.0036
344 GAMMA-GLUTAMYLTRANSFERASE INCREASED 78 0.0035
345 DYSTONIA 68 0.0035
346 HOMICIDAL IDEATION 14 0.0034
347 OBESITY 55 0.0034
348 DECUBITUS ULCER 28 0.0034
349 MOTOR DYSFUNCTION 35 0.0034
350 FOOD CRAVING 18 0.0034
351 BLOOD PRESSURE FLUCTUATION 82 0.0034
352 GASTRIC INFECTION 13 0.0034
353 BLOOD DISORDER 27 0.0034
354 PULSE ABSENT 16 0.0034
355 THERAPEUTIC PRODUCT EFFECT VARIABLE 13 0.0033
356 HEPATITIS CHOLESTATIC 20 0.0033
357 VENTRICULAR SEPTAL DEFECT 19 0.0033
358 SCREAMING 21 0.0033
359 INGUINAL HERNIA 20 0.0033
360 LEFT VENTRICULAR DYSFUNCTION 22 0.0033
361 SUBDURAL HAEMATOMA 47 0.0033
362 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 29 0.0033
363 LEFT VENTRICULAR HYPERTROPHY 14 0.0033
364 CEREBRAL ATROPHY 13 0.0033
365 CATATONIA 17 0.0032
366 PRODUCT ADMINISTRATION ERROR 65 0.0032
367 UNRESPONSIVE TO STIMULI 82 0.0032
368 SKIN ABRASION 15 0.0032
369 DRUG DEPENDENCE 510 0.0032
370 HALLUCINATION 239 0.0032
371 PERICARDITIS 53 0.0032
372 TRANSAMINASES INCREASED 70 0.0031
373 DISSOCIATION 24 0.0031
374 CARDIOMYOPATHY 46 0.0031
375 CLOSTRIDIUM DIFFICILE COLITIS 33 0.0031
376 RESTLESS LEGS SYNDROME 56 0.0031
377 URINE ABNORMALITY 14 0.0031
378 LOSS OF CONSCIOUSNESS 394 0.0031
379 BLOOD CREATINE PHOSPHOKINASE INCREASED 88 0.0031
380 BUNDLE BRANCH BLOCK RIGHT 14 0.0030
381 DRUG LEVEL DECREASED 31 0.0030
382 ANURIA 26 0.0030
383 HYPERTRANSAMINASAEMIA 21 0.0030
384 HEPATIC ENZYME ABNORMAL 15 0.0030
385 SENSORY DISTURBANCE 48 0.0030
386 SENSORY LOSS 24 0.0030
387 ABORTION INDUCED 28 0.0030
388 BEDRIDDEN 39 0.0030
389 HYPOKINESIA 43 0.0030
390 GALACTORRHOEA 19 0.0030
391 ABNORMAL FAECES 24 0.0029
392 ENDOCARDITIS 15 0.0029
393 PREMATURE BABY 88 0.0029
394 HAEMATOMA 75 0.0029
395 ATRIAL FLUTTER 23 0.0029
396 TACHYPNOEA 39 0.0029
397 SPUTUM DISCOLOURED 27 0.0028
398 HYPERCALCAEMIA 35 0.0028
399 FEBRILE NEUTROPENIA 188 0.0028
400 DEMENTIA 79 0.0028
401 GENERAL PHYSICAL HEALTH DETERIORATION 327 0.0028
402 CIRCULATORY COLLAPSE 48 0.0028
403 GRAND MAL CONVULSION 26 0.0028
404 VENTRICULAR TACHYCARDIA 46 0.0028
405 EXERCISE TOLERANCE DECREASED 16 0.0028
406 TOXIC SKIN ERUPTION 28 0.0028
407 KLEBSIELLA INFECTION 14 0.0028
408 ISCHAEMIC STROKE 49 0.0027
409 SLEEP APNOEA SYNDROME 52 0.0027
410 BACTERAEMIA 32 0.0027
411 BRAIN INJURY 27 0.0027
412 HAEMORRHAGIC STROKE 21 0.0027
413 POLYURIA 22 0.0027
414 ARRHYTHMIA 127 0.0027
415 POLYNEUROPATHY 32 0.0027
416 HORMONE LEVEL ABNORMAL 13 0.0027
417 MENTAL IMPAIRMENT 64 0.0026
418 PANIC REACTION 19 0.0026
419 ABDOMINAL HERNIA 12 0.0026
420 TROPONIN INCREASED 20 0.0026
421 VENTRICULAR FIBRILLATION 29 0.0026
422 STEVENS-JOHNSON SYNDROME 58 0.0026
423 PANIC ATTACK 95 0.0026
424 FLUID INTAKE REDUCED 13 0.0026
425 ACCIDENT 31 0.0026
426 PETECHIAE 27 0.0026
427 NEPHROPATHY TOXIC 29 0.0026
428 HYPERSOMNIA 74 0.0026
429 SLEEP DISORDER 182 0.0026
430 EMPHYSEMA 26 0.0026
431 HEPATIC ENCEPHALOPATHY 24 0.0026
432 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 13 0.0026
433 JAUNDICE 69 0.0026
434 NERVOUS SYSTEM DISORDER 80 0.0026
435 HEAD INJURY 81 0.0026
436 FOETAL EXPOSURE DURING PREGNANCY 207 0.0025
437 CARDIAC ARREST 210 0.0025
438 NIGHTMARE 88 0.0025
439 HEPATITIS 65 0.0025
440 POST-TRAUMATIC STRESS DISORDER 17 0.0025
441 CACHEXIA 13 0.0025
442 PAROSMIA 19 0.0025
443 GENERALISED OEDEMA 31 0.0025
444 PERIORBITAL OEDEMA 13 0.0025
445 RESPIRATORY ARREST 69 0.0025
446 CEREBRAL HAEMORRHAGE 89 0.0025
447 MATERNAL DRUGS AFFECTING FOETUS 19 0.0025
448 PERSONALITY CHANGE 23 0.0025
449 HYPERPROLACTINAEMIA 16 0.0025
450 CARDIAC FAILURE 198 0.0025
451 NEUTROPHILIA 14 0.0025
452 SUBARACHNOID HAEMORRHAGE 25 0.0025
453 LUNG DISORDER 120 0.0024
454 EMOTIONAL DISORDER 75 0.0024
455 THROMBOCYTOPENIA 271 0.0024
456 MALNUTRITION 27 0.0024
457 TUBULOINTERSTITIAL NEPHRITIS 45 0.0024
458 PERIPHERAL SENSORY NEUROPATHY 14 0.0024
459 BLOOD ALKALINE PHOSPHATASE INCREASED 59 0.0024
460 BOWEL MOVEMENT IRREGULARITY 18 0.0023
461 SYMPTOM RECURRENCE 14 0.0023
462 HAEMOLYSIS 18 0.0023
463 ELECTROLYTE IMBALANCE 27 0.0023
464 RESPIRATION ABNORMAL 16 0.0023
465 PARANOIA 40 0.0023
466 RESPIRATORY FAILURE 169 0.0023
467 HYPOALBUMINAEMIA 18 0.0023
468 INTERNATIONAL NORMALISED RATIO INCREASED 66 0.0023
469 MUSCLE STRAIN 20 0.0023
470 PYELONEPHRITIS 20 0.0023
471 THINKING ABNORMAL 43 0.0023
472 HYPOPHOSPHATAEMIA 17 0.0023
473 MITRAL VALVE INCOMPETENCE 26 0.0023
474 VERTIGO 139 0.0023
475 MATERNAL EXPOSURE DURING PREGNANCY 203 0.0023
476 TRICUSPID VALVE INCOMPETENCE 18 0.0023
477 SLUGGISHNESS 23 0.0023
478 DIVERTICULUM 16 0.0022
479 DIARRHOEA HAEMORRHAGIC 21 0.0022
480 ACUTE RESPIRATORY FAILURE 43 0.0022
481 LIVER FUNCTION TEST ABNORMAL 65 0.0022
482 MELAENA 49 0.0022
483 FRACTURE 42 0.0022
484 FEELING OF BODY TEMPERATURE CHANGE 13 0.0022
485 BLOOD LACTATE DEHYDROGENASE INCREASED 35 0.0022
486 FAECES SOFT 16 0.0022
487 TARDIVE DYSKINESIA 62 0.0022
488 CYTOKINE RELEASE SYNDROME 44 0.0022
489 PNEUMOCYSTIS JIROVECII PNEUMONIA 22 0.0022
490 MUCOSAL INFLAMMATION 57 0.0022
491 FEELING DRUNK 16 0.0022
492 HYPOPHAGIA 55 0.0021
493 ATRIAL SEPTAL DEFECT 18 0.0021
494 EUPHORIC MOOD 22 0.0021
495 HEPATIC STEATOSIS 40 0.0021
496 PANCYTOPENIA 120 0.0021
497 TREMOR 356 0.0021
498 HEPATOMEGALY 21 0.0021
499 HYPERBILIRUBINAEMIA 22 0.0021
500 DYSSTASIA 62 0.0021
501 ACUTE HEPATIC FAILURE 29 0.0021
502 RECTAL HAEMORRHAGE 90 0.0021
503 URINARY INCONTINENCE 62 0.0021
504 C-REACTIVE PROTEIN INCREASED 76 0.0021
505 LIPASE INCREASED 16 0.0021
506 FEAR 56 0.0021
507 HALLUCINATION, AUDITORY 33 0.0021
508 GENERAL PHYSICAL CONDITION ABNORMAL 14 0.0021
509 HYPERGLYCAEMIA 75 0.0021
510 HEART RATE DECREASED 72 0.0020
511 BLOOD PRESSURE DECREASED 136 0.0020
512 INITIAL INSOMNIA 21 0.0020
513 PULMONARY HAEMORRHAGE 16 0.0020
514 EYE MOVEMENT DISORDER 14 0.0020
515 DECREASED ACTIVITY 22 0.0020
516 ELECTROCARDIOGRAM ABNORMAL 16 0.0020
517 LEUKOPENIA 102 0.0020
518 DEFORMITY 19 0.0020
519 MENTAL DISORDER 88 0.0020
520 ARTERIOSCLEROSIS 19 0.0020
521 OESOPHAGITIS 22 0.0020
522 PEMPHIGOID 15 0.0020
523 NOCTURIA 24 0.0020
524 BONE MARROW FAILURE 40 0.0020
525 IRRITABILITY 118 0.0020
526 HYPERAESTHESIA 16 0.0019
527 ANOREXIA 25 0.0019
528 ACUTE CORONARY SYNDROME 16 0.0019
529 PRODUCT PRESCRIBING ERROR 46 0.0019
530 EMBOLISM 16 0.0019
531 GASTROENTERITIS 28 0.0019
532 HYPERHIDROSIS 247 0.0019
533 HEMIPARESIS 32 0.0019
534 LIVER FUNCTION TEST INCREASED 40 0.0019
535 DEHYDRATION 248 0.0019
536 CYANOSIS 29 0.0018
537 LYMPHOPENIA 26 0.0018
538 BLOOD CALCIUM INCREASED 16 0.0018
539 WEIGHT FLUCTUATION 19 0.0018
540 RIB FRACTURE 37 0.0018
541 CHOKING 35 0.0018
542 THIRST 32 0.0018
543 NEUTROPENIA 243 0.0018
544 ANAPHYLACTIC SHOCK 46 0.0018
545 SKIN INFECTION 20 0.0018
546 MEDICATION ERROR 99 0.0018
547 INTERSTITIAL LUNG DISEASE 86 0.0018
548 OEDEMA PERIPHERAL 216 0.0018
549 NODULE 23 0.0018
550 ATELECTASIS 17 0.0018
551 DEPRESSED MOOD 93 0.0018
552 DIABETES MELLITUS INADEQUATE CONTROL 31 0.0017
553 MICTURITION URGENCY 20 0.0017
554 PNEUMONIA BACTERIAL 16 0.0017
555 BLOOD BILIRUBIN INCREASED 47 0.0017
556 POOR VENOUS ACCESS 18 0.0017
557 DYSPHAGIA 165 0.0017
558 EATING DISORDER 37 0.0017
559 HYPERTHYROIDISM 25 0.0017
560 SEPTIC SHOCK 75 0.0017
561 APHASIA 52 0.0017
562 AMNESIA 112 0.0017
563 WOUND 48 0.0017
564 VASCULITIS 20 0.0017
565 ROTATOR CUFF SYNDROME 22 0.0017
566 ASPARTATE AMINOTRANSFERASE INCREASED 91 0.0017
567 HEPATIC CIRRHOSIS 32 0.0017
568 HIATUS HERNIA 22 0.0017
569 DRUG-INDUCED LIVER INJURY 53 0.0017
570 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 16 0.0017
571 GASTROINTESTINAL INFECTION 15 0.0017
572 EJECTION FRACTION DECREASED 26 0.0017
573 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
574 SYNOVITIS 30 0.0017
575 SPEECH DISORDER 87 0.0017
576 BIPOLAR DISORDER 18 0.0017
577 AFFECTIVE DISORDER 13 0.0017
578 RENAL FAILURE 219 0.0016
579 VITAMIN D DEFICIENCY 16 0.0016
580 DISSEMINATED INTRAVASCULAR COAGULATION 23 0.0016
581 MOOD SWINGS 52 0.0016
582 LIVER INJURY 40 0.0016
583 DEPRESSION 370 0.0016
584 CARDIOMEGALY 20 0.0016
585 UROSEPSIS 15 0.0016
586 MEMORY IMPAIRMENT 223 0.0016
587 ANXIETY 460 0.0016
588 PHARYNGITIS 20 0.0016
589 INFLAMMATION 83 0.0016
590 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 77 0.0016
591 PERITONITIS 33 0.0016
592 SEIZURE 183 0.0016
593 RESPIRATORY RATE INCREASED 14 0.0016
594 HEPATITIS C 19 0.0016
595 SYNCOPE 157 0.0016
596 BODY TEMPERATURE INCREASED 32 0.0016
597 MOUTH ULCERATION 33 0.0016
598 WHITE BLOOD CELL COUNT INCREASED 60 0.0016
599 PNEUMONIA 506 0.0016
600 MIDDLE INSOMNIA 29 0.0016
601 WOUND INFECTION 17 0.0016
602 HAEMOGLOBIN DECREASED 159 0.0015
603 MUSCLE TIGHTNESS 25 0.0015
604 FACE OEDEMA 26 0.0015
605 DIABETIC KETOACIDOSIS 37 0.0015
606 HYPERTENSION 326 0.0015
607 SPLENOMEGALY 18 0.0015
608 COLITIS 58 0.0015
609 TINNITUS 70 0.0015
610 VITAMIN D DECREASED 13 0.0015
611 ATAXIA 18 0.0015
612 IRON DEFICIENCY ANAEMIA 14 0.0015
613 PSEUDOMONAS INFECTION 13 0.0015
614 PULMONARY EMBOLISM 144 0.0015
615 PANCREATITIS 80 0.0015
616 LETHARGY 87 0.0015
617 ANGER 51 0.0015
618 WRIST FRACTURE 18 0.0015
619 COAGULOPATHY 25 0.0015
620 ABDOMINAL PAIN 349 0.0015
621 PAIN 920 0.0015
622 CARDIOVASCULAR DISORDER 38 0.0015
623 MOVEMENT DISORDER 48 0.0015
624 FLANK PAIN 14 0.0015
625 RENAL FAILURE ACUTE 63 0.0015
626 IMMUNOSUPPRESSION 13 0.0015
627 PROTEINURIA 28 0.0015
628 SKIN ULCER 38 0.0015
629 ANAEMIA 279 0.0015
630 EYELID OEDEMA 17 0.0015
631 CONDITION AGGRAVATED 441 0.0014
632 ALANINE AMINOTRANSFERASE INCREASED 89 0.0014
633 HAEMORRHOIDS 28 0.0014
634 CONTRAINDICATED PRODUCT ADMINISTERED 43 0.0014
635 MUSCULOSKELETAL STIFFNESS 124 0.0014
636 OSTEOARTHRITIS 60 0.0014
637 PLEURAL EFFUSION 86 0.0014
638 OEDEMA 76 0.0014
639 DYSPNOEA 792 0.0014
640 PALLOR 38 0.0014
641 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 99 0.0014
642 VOMITING 654 0.0014
643 PRODUCTIVE COUGH 66 0.0014
644 DRUG EXPOSURE DURING PREGNANCY 47 0.0014
645 BLOOD SODIUM DECREASED 26 0.0014
646 MUSCULOSKELETAL PAIN 72 0.0014
647 INTENTIONAL PRODUCT USE ISSUE 120 0.0014
648 GAIT DISTURBANCE 262 0.0014
649 ANAPHYLACTIC REACTION 75 0.0014
650 HAEMATEMESIS 34 0.0013
651 INTERVERTEBRAL DISC PROTRUSION 29 0.0013
652 HAEMOPTYSIS 37 0.0013
653 WEIGHT DECREASED 370 0.0013
654 HEPATIC ENZYME INCREASED 90 0.0013
655 MOOD ALTERED 36 0.0013
656 ATRIAL FIBRILLATION 128 0.0013
657 INCREASED APPETITE 25 0.0013
658 BLOOD CREATININE INCREASED 85 0.0013
659 DEVICE RELATED INFECTION 20 0.0013
660 PULMONARY HYPERTENSION 27 0.0013
661 HAND DEFORMITY 17 0.0013
662 GASTRITIS 34 0.0013
663 PRESCRIBED OVERDOSE 25 0.0013
664 LIMB INJURY 35 0.0013
665 SKIN LACERATION 14 0.0013
666 DRUG WITHDRAWAL SYNDROME NEONATAL 19 0.0013
667 CHOLELITHIASIS 42 0.0013
668 DISCOMFORT 78 0.0013
669 RENAL IMPAIRMENT 107 0.0013
670 RESPIRATORY TRACT INFECTION 33 0.0013
671 EAR DISCOMFORT 13 0.0013
672 DIVERTICULITIS 35 0.0013
673 BRONCHOSPASM 18 0.0013
674 PRODUCT USE IN UNAPPROVED INDICATION 311 0.0013
675 IMPAIRED QUALITY OF LIFE 18 0.0013
676 UPPER GASTROINTESTINAL HAEMORRHAGE 21 0.0012
677 OCULAR DISCOMFORT 14 0.0012
678 BLOOD TRIGLYCERIDES INCREASED 22 0.0012
679 STAPHYLOCOCCAL INFECTION 41 0.0012
680 BLOOD PRESSURE INCREASED 190 0.0012
681 DRUG WITHDRAWAL SYNDROME 109 0.0012
682 ASTHENIA 467 0.0012
683 ADRENAL INSUFFICIENCY 15 0.0012
684 ABNORMAL DREAMS 34 0.0012
685 ASCITES 36 0.0012
686 TREATMENT NONCOMPLIANCE 67 0.0012
687 MULTI-ORGAN FAILURE 21 0.0012
688 SOPOR 16 0.0012
689 SECRETION DISCHARGE 15 0.0012
690 INTENTIONAL DRUG MISUSE 25 0.0012
691 INTESTINAL OBSTRUCTION 45 0.0012
692 PRODUCT PRESCRIBING ISSUE 26 0.0012
693 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 62 0.0012
694 FEEDING DISORDER 24 0.0012
695 CELLULITIS 59 0.0012
696 MUSCULAR WEAKNESS 133 0.0012
697 RESPIRATORY DISORDER 35 0.0012
698 PERICARDIAL EFFUSION 27 0.0012
699 DECREASED APPETITE 271 0.0012
700 HYPOACUSIS 50 0.0012
701 DRY MOUTH 94 0.0012
702 HEPATIC FUNCTION ABNORMAL 43 0.0012
703 ANGINA PECTORIS 33 0.0012
704 NEURALGIA 28 0.0012
705 ORAL DISCOMFORT 16 0.0012
706 EYE INFECTION 13 0.0012
707 HIP FRACTURE 37 0.0011
708 WEIGHT INCREASED 257 0.0011
709 DEAFNESS 30 0.0011
710 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
711 DIZZINESS 569 0.0011
712 HERNIA 22 0.0011
713 URINARY TRACT INFECTION 194 0.0011
714 PYREXIA 392 0.0011
715 CONJUNCTIVITIS 21 0.0011
716 ULCER 18 0.0011
717 CYST 14 0.0011
718 CORONARY ARTERY DISEASE 34 0.0011
719 BRONCHITIS 83 0.0011
720 CAESAREAN SECTION 13 0.0011
721 FAECES DISCOLOURED 24 0.0011
722 BLOOD URINE PRESENT 21 0.0011
723 MUSCULOSKELETAL DISCOMFORT 19 0.0011
724 COVID-19 PNEUMONIA 13 0.0011
725 MUSCULOSKELETAL CHEST PAIN 17 0.0011
726 HAEMATURIA 37 0.0011
727 PULMONARY MASS 16 0.0011
728 CONTUSION 103 0.0011
729 FIBROMYALGIA 26 0.0011
730 JOINT STIFFNESS 28 0.0011
731 CONVULSION 61 0.0011
732 PNEUMONITIS 29 0.0011
733 INSOMNIA 283 0.0011
734 DYSPNOEA EXERTIONAL 40 0.0011
735 PALPITATIONS 124 0.0011
736 SKIN LESION 29 0.0011
737 PRESCRIBED UNDERDOSE 21 0.0011
738 MALAISE 461 0.0011
739 HEART RATE INCREASED 104 0.0010
740 ILEUS 13 0.0010
741 INFUSION RELATED REACTION 69 0.0010
742 NECK PAIN 58 0.0010
743 LIVER DISORDER 46 0.0010
744 FLUID OVERLOAD 15 0.0010
745 EPISTAXIS 77 0.0010
746 DIARRHOEA 664 0.0010
747 IMPAIRED GASTRIC EMPTYING 14 0.0010
748 DEEP VEIN THROMBOSIS 66 0.0010
749 FEELING COLD 28 0.0010
750 CYSTITIS 32 0.0010
751 FOOT FRACTURE 19 0.0010
752 DIPLOPIA 26 0.0010
753 SPINAL FRACTURE 20 0.0010
754 MUSCLE TWITCHING 23 0.0010
755 GASTROENTERITIS VIRAL 18 0.0010
756 DEVICE OCCLUSION 14 0.0010
757 LOCALISED INFECTION 24 0.0010
758 ARTHRITIS 78 0.0010
759 HEPATOTOXICITY 22 0.0010
760 DEATH 851 0.0010
761 BONE DISORDER 18 0.0010
762 GASTRIC CANCER 25 0.0010
763 PARAESTHESIA 155 0.0010
764 RASH ERYTHEMATOUS 47 0.0010
765 CEREBRAL INFARCTION 24 0.0010
766 METASTASES TO BONE 16 0.0010
767 AMENORRHOEA 17 0.0010
768 NAUSEA 767 0.0010
769 GASTROOESOPHAGEAL REFLUX DISEASE 78 0.0010
770 VISUAL IMPAIRMENT 120 0.0010
771 SEPSIS 108 0.0010
772 DRUG ERUPTION 17 0.0010
773 GAIT INABILITY 32 0.0010
774 UPPER LIMB FRACTURE 19 0.0010
775 MYALGIA 162 0.0010
776 GASTRIC ULCER 18 0.0009
777 PREMATURE DELIVERY 15 0.0009
778 HYPOTHYROIDISM 30 0.0009
779 TOOTHACHE 17 0.0009
780 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
781 LYMPHADENOPATHY 33 0.0009
782 BLOOD POTASSIUM DECREASED 28 0.0009
783 ABDOMINAL DISTENSION 97 0.0009
784 INFECTION 134 0.0009
785 INJURY 65 0.0009
786 HAEMATOCHEZIA 51 0.0009
787 CHEST PAIN 171 0.0009
788 TYPE 2 DIABETES MELLITUS 31 0.0009
789 KIDNEY INFECTION 18 0.0009
790 EXPOSURE DURING PREGNANCY 57 0.0009
791 TENDONITIS 14 0.0009
792 FEMUR FRACTURE 28 0.0009
793 LIP SWELLING 30 0.0009
794 DYSURIA 33 0.0009
795 GALLBLADDER DISORDER 16 0.0009
796 FATIGUE 697 0.0009
797 SKIN DISCOLOURATION 41 0.0009
798 BONE PAIN 52 0.0009
799 CARDIAC DISORDER 83 0.0009
800 GASTROINTESTINAL HAEMORRHAGE 74 0.0009
801 ROAD TRAFFIC ACCIDENT 37 0.0009
802 MYOCARDIAL INFARCTION 154 0.0009
803 INCORRECT PRODUCT ADMINISTRATION DURATION 19 0.0009
804 ORAL HERPES 17 0.0009
805 GASTROINTESTINAL DISORDER 78 0.0009
806 ANGIOEDEMA 38 0.0009
807 BACTERIAL INFECTION 16 0.0009
808 ERECTILE DYSFUNCTION 22 0.0009
809 OFF LABEL USE 749 0.0009
810 OSTEOPOROSIS 35 0.0009
811 CHROMATURIA 19 0.0008
812 BURNING SENSATION 59 0.0008
813 BACK PAIN 194 0.0008
814 MENINGIOMA 13 0.0008
815 FLATULENCE 47 0.0008
816 EAR INFECTION 22 0.0008
817 EAR PAIN 16 0.0008
818 IMPAIRED HEALING 27 0.0008
819 CHEST DISCOMFORT 83 0.0008
820 SKIN DISORDER 27 0.0008
821 SWOLLEN TONGUE 25 0.0008
822 COLD SWEAT 14 0.0008
823 HAEMORRHAGE 83 0.0008
824 MENTAL STATUS CHANGES 22 0.0008
825 MULTIPLE FRACTURES 13 0.0008
826 GASTRIC DISORDER 27 0.0008
827 BLISTER 44 0.0008
828 PULMONARY FIBROSIS 15 0.0008
829 PRESYNCOPE 19 0.0008
830 DRUG INTOLERANCE 75 0.0008
831 NASOPHARYNGITIS 143 0.0008
832 PAIN IN EXTREMITY 228 0.0008
833 TRANSIENT ISCHAEMIC ATTACK 26 0.0008
834 NERVOUSNESS 40 0.0008
835 TOOTH DISORDER 17 0.0008
836 ANHEDONIA 20 0.0008
837 DIABETES MELLITUS 58 0.0008
838 RASH PRURITIC 41 0.0008
839 HAEMATOCRIT DECREASED 15 0.0008
840 INFLUENZA 84 0.0008
841 DYSPEPSIA 74 0.0008
842 ARTHRALGIA 312 0.0007
843 FEELING HOT 46 0.0007
844 PREGNANCY 15 0.0007
845 CRYING 27 0.0007
846 PAIN OF SKIN 20 0.0007
847 PRODUCT USE ISSUE 139 0.0007
848 CHILLS 86 0.0007
849 ECZEMA 38 0.0007
850 THERAPEUTIC RESPONSE SHORTENED 24 0.0007
851 FEELING ABNORMAL 173 0.0007
852 AGEUSIA 18 0.0007
853 NEOPLASM PROGRESSION 25 0.0007
854 GLOSSODYNIA 16 0.0007
855 HERPES ZOSTER 41 0.0007
856 ACUTE MYOCARDIAL INFARCTION 21 0.0007
857 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
858 ARTHROPATHY 39 0.0007
859 DYSPHONIA 41 0.0007
860 RED BLOOD CELL COUNT DECREASED 20 0.0007
861 MUSCLE SPASMS 128 0.0007
862 BLOOD CHOLESTEROL INCREASED 32 0.0007
863 MIGRAINE 65 0.0007
864 HEADACHE 426 0.0007
865 HYPOAESTHESIA 101 0.0007
866 CEREBROVASCULAR ACCIDENT 114 0.0007
867 ABDOMINAL PAIN UPPER 138 0.0007
868 SNEEZING 15 0.0007
869 EXTRA DOSE ADMINISTERED 27 0.0007
870 FREQUENT BOWEL MOVEMENTS 18 0.0007
871 HEART RATE IRREGULAR 15 0.0007
872 HOT FLUSH 50 0.0007
873 VIRAL INFECTION 22 0.0007
874 RETCHING 14 0.0007
875 SINUS DISORDER 13 0.0007
876 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 118 0.0007
877 NEPHROLITHIASIS 30 0.0007
878 DISEASE PROGRESSION 77 0.0007
879 SKIN CANCER 14 0.0006
880 FLUID RETENTION 33 0.0006
881 ABDOMINAL DISCOMFORT 108 0.0006
882 PRODUCT DISPENSING ERROR 14 0.0006
883 COUGH 180 0.0006
884 VISION BLURRED 88 0.0006
885 OROPHARYNGEAL PAIN 59 0.0006
886 MALIGNANT NEOPLASM PROGRESSION 65 0.0006
887 RASH MACULAR 22 0.0006
888 WHEEZING 37 0.0006
889 JOINT SWELLING 75 0.0006
890 GYNAECOMASTIA 19 0.0006
891 PROCEDURAL PAIN 17 0.0006
892 SWELLING 57 0.0006
893 LUNG NEOPLASM MALIGNANT 25 0.0006
894 UNEVALUABLE EVENT 46 0.0006
895 IRRITABLE BOWEL SYNDROME 13 0.0006
896 ALOPECIA 116 0.0006
897 NIGHT SWEATS 19 0.0006
898 ORAL PAIN 13 0.0006
899 THERAPEUTIC RESPONSE UNEXPECTED 26 0.0006
900 EYE DISORDER 19 0.0006
901 POLLAKIURIA 24 0.0006
902 ABORTION SPONTANEOUS 23 0.0006
903 ERYTHEMA 117 0.0006
904 LIMB DISCOMFORT 17 0.0005
905 RHEUMATOID ARTHRITIS 62 0.0005
906 STOMATITIS 33 0.0005
907 RASH GENERALISED 14 0.0005
908 COVID-19 94 0.0005
909 INCORRECT DOSE ADMINISTERED 122 0.0005
910 ILLNESS 55 0.0005
911 LACRIMATION INCREASED 16 0.0005
912 ILL-DEFINED DISORDER 32 0.0005
913 ABASIA 13 0.0005
914 DISEASE RECURRENCE 25 0.0005
915 OSTEONECROSIS OF JAW 13 0.0005
916 ASTHMA 59 0.0005
917 PANCREATIC CARCINOMA 15 0.0005
918 NEUTROPHIL COUNT DECREASED 21 0.0005
919 PRURITUS 198 0.0005
920 ABDOMINAL PAIN LOWER 13 0.0005
921 DYSGEUSIA 38 0.0005
922 NASAL CONGESTION 30 0.0005
923 DRUG INEFFECTIVE 668 0.0005
924 SWELLING FACE 33 0.0005
925 DRY EYE 25 0.0005
926 THROAT TIGHTNESS 13 0.0005
927 FUNGAL INFECTION 16 0.0005
928 RENAL DISORDER 22 0.0005
929 PAIN IN JAW 13 0.0005
930 URTICARIA 74 0.0004
931 CATARACT 26 0.0004
932 RASH 190 0.0004
933 EYE SWELLING 16 0.0004
934 THROMBOSIS 34 0.0004
935 VISUAL ACUITY REDUCED 14 0.0004
936 NEUROPATHY PERIPHERAL 40 0.0004
937 SINUSITIS 43 0.0004
938 MULTIPLE SCLEROSIS 20 0.0004
939 WHITE BLOOD CELL COUNT DECREASED 44 0.0004
940 NEOPLASM MALIGNANT 27 0.0004
941 RHINORRHOEA 26 0.0004
942 THROAT IRRITATION 18 0.0004
943 OSTEONECROSIS 13 0.0004
944 LOWER RESPIRATORY TRACT INFECTION 18 0.0004
945 BLOOD GLUCOSE DECREASED 19 0.0004
946 DRUG EFFECT DECREASED 21 0.0004
947 PERIPHERAL SWELLING 60 0.0004
948 BLOOD GLUCOSE INCREASED 73 0.0004
949 PLASMA CELL MYELOMA 15 0.0004
950 DEPENDENCE 21 0.0004
951 PRODUCT SUBSTITUTION ISSUE 22 0.0004
952 SKIN BURNING SENSATION 27 0.0004
953 INFLUENZA LIKE ILLNESS 31 0.0004
954 HOSPITALISATION 57 0.0004
955 UNDERDOSE 27 0.0004
956 ACNE 28 0.0004
957 ADVERSE EVENT 34 0.0004
958 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
959 HYPERSENSITIVITY 68 0.0004
960 THERAPEUTIC RESPONSE DECREASED 22 0.0004
961 DRUG EFFECT INCOMPLETE 13 0.0004
962 ADVERSE DRUG REACTION 32 0.0004
963 EYE PAIN 20 0.0004
964 FLUSHING 36 0.0004
965 MULTIPLE SCLEROSIS RELAPSE 24 0.0003
966 PLATELET COUNT DECREASED 37 0.0003
967 EMOTIONAL DISTRESS 42 0.0003
968 THERAPY NON-RESPONDER 15 0.0003
969 PSORIASIS 42 0.0003
970 CHRONIC KIDNEY DISEASE 24 0.0003
971 COLITIS ULCERATIVE 14 0.0003
972 SKIN EXFOLIATION 25 0.0003
973 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
974 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
975 SURGERY 17 0.0003
976 DEVICE ISSUE 25 0.0003
977 CARDIAC FAILURE CONGESTIVE 22 0.0003
978 PROSTATE CANCER 22 0.0003
979 THERAPY CESSATION 14 0.0003
980 BREAST CANCER 24 0.0003
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
982 EYE IRRITATION 13 0.0002
983 INJECTION SITE REACTION 15 0.0002
984 TREATMENT FAILURE 16 0.0002
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 38 0.0002
986 DRY SKIN 23 0.0002
987 NO ADVERSE EVENT 29 0.0002
988 INJECTION SITE ERYTHEMA 18 0.0001
989 PRODUCT DOSE OMISSION ISSUE 42 0.0001
990 INJECTION SITE PAIN 39 0.0001
991 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
992 DRUG DOSE OMISSION 18 0.0001